| Autor: |
Gupta D, Lammersfeld CA, Vashi PG, Dahlk S, Grutsch JF, Lis CG |
| Zdroj: |
Clinical Ovarian Cancer; May2009, Vol. 2 Issue 1, p52-56, 5p |
| Abstrakt: |
Background: The medical literature shows several examples of an inverse relationship between serum albumin and mortality in patients with advanced cancer. Because malnutrition can be a frequent manifestation in ovarian cancer, we investigated the prognostic role of serum albumin in patients with ovarian cancer treated in an integrative cancer treatment setting. Materials and Methods: We evaluated 213 histologically confirmed case series of ovarian cancer patients treated at Cancer Treatment Centers of America® between January 2001 and May 2006. Serum albumin was divided into 2 categories of >/= 3.6 g/dL and /= 3.6 g/dL, and 78 patients had a score of /= 3.6 g/dL scores had a median survival of 23.3 months (95% CI, 16.5-30.1 months), whereas those with
|
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full Text from ScienceDirect